These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35618774)

  • 1. Immunosuppression broadens evolutionary pathways to drug resistance and treatment failure during Acinetobacter baumannii pneumonia in mice.
    Huo W; Busch LM; Hernandez-Bird J; Hamami E; Marshall CW; Geisinger E; Cooper VS; van Opijnen T; Rosch JW; Isberg RR
    Nat Microbiol; 2022 Jun; 7(6):796-809. PubMed ID: 35618774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii.
    Jo J; Ko KS
    Microbiol Spectr; 2021 Oct; 9(2):e0101021. PubMed ID: 34523993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and WGS-derived antimicrobial resistance profiles of clinical and non-clinical Acinetobacter baumannii isolates from Germany and Vietnam.
    Wareth G; Linde J; Hammer P; Nguyen NH; Nguyen TNM; Splettstoesser WD; Makarewicz O; Neubauer H; Sprague LD; Pletz MW
    Int J Antimicrob Agents; 2020 Oct; 56(4):106127. PubMed ID: 32750418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapy.
    Shin B; Park W
    J Microbiol; 2017 Nov; 55(11):837-849. PubMed ID: 29076065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Omega-3 Fatty Acids on the Evolution of Acinetobacter baumannii Drug Resistance.
    Zang M; Adams FG; Hassan KA; Eijkelkamp BA
    Microbiol Spectr; 2021 Dec; 9(3):e0145521. PubMed ID: 34762519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surprising synergy of dual translation inhibition vs. Acinetobacter baumannii and other multidrug-resistant bacterial pathogens.
    Dillon N; Holland M; Tsunemoto H; Hancock B; Cornax I; Pogliano J; Sakoulas G; Nizet V
    EBioMedicine; 2019 Aug; 46():193-201. PubMed ID: 31353294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt.
    Jalal D; Elzayat MG; Diab AA; El-Shqanqery HE; Samir O; Bakry U; Hassan R; Elanany M; Shalaby L; Sayed AA
    mSphere; 2021 Dec; 6(6):e0072521. PubMed ID: 34787450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii.
    Kamoshida G; Yamada N; Nakamura T; Yamaguchi D; Kai D; Yamashita M; Hayashi C; Kanda N; Sakaguchi M; Morimoto H; Sawada T; Okada T; Kaya Y; Takemoto N; Yahiro K
    Microbiol Spectr; 2022 Oct; 10(5):e0192822. PubMed ID: 36173297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.
    Wieczorek P; Sacha P; Hauschild T; Zórawski M; Krawczyk M; Tryniszewska E
    Folia Histochem Cytobiol; 2008; 46(3):257-67. PubMed ID: 19056528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of aminoglycoside resistance gene aphA1 in Acinetobacter baumannii results in tobramycin therapy failure.
    McGann P; Courvalin P; Snesrud E; Clifford RJ; Yoon EJ; Onmus-Leone F; Ong AC; Kwak YI; Grillot-Courvalin C; Lesho E; Waterman PE
    mBio; 2014 Apr; 5(2):e00915. PubMed ID: 24757213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Genome-Editing Platform for Drug-Resistant Acinetobacter baumannii Reveals an AdeR-Unrelated Tigecycline Resistance Mechanism.
    Trebosc V; Gartenmann S; Royet K; Manfredi P; Tötzl M; Schellhorn B; Pieren M; Tigges M; Lociuro S; Sennhenn PC; Gitzinger M; Bumann D; Kemmer C
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7263-7271. PubMed ID: 27671072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients.
    Zhang J; Xie J; Li H; Wang Z; Yin Y; Wang S; Chen H; Wang Q; Wang H
    Microbiol Spectr; 2022 Feb; 10(1):e0159321. PubMed ID: 35044218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole Genome Analysis of Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates in Thailand.
    Chopjitt P; Kerdsin A; Takeuchi D; Hatrongjit R; Boueroy P; Akeda Y; Tomono K; Hamada S
    Infect Disord Drug Targets; 2021; 21(5):e270421188042. PubMed ID: 33200701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of the Ade Resistance-Nodulation-Cell Division-Type Efflux Pumps to Fitness and Pathogenesis of Acinetobacter baumannii.
    Yoon EJ; Balloy V; Fiette L; Chignard M; Courvalin P; Grillot-Courvalin C
    mBio; 2016 May; 7(3):. PubMed ID: 27247231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
    Warner WA; Kuang SN; Hernandez R; Chong MC; Ewing PJ; Fleischer J; Meng J; Chu S; Terashita D; English L; Chen W; Xu HH
    BMC Infect Dis; 2016 May; 16():194. PubMed ID: 27146090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic resistance determinants of multidrug-resistant Acinetobacter baumannii clinical isolates in Algeria.
    Bakour S; Touati A; Sahli F; Ameur AA; Haouchine D; Rolain JM
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):529-31. PubMed ID: 23688522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic basis of antibiotic resistance in pathogenic Acinetobacter species.
    Poirel L; Bonnin RA; Nordmann P
    IUBMB Life; 2011 Dec; 63(12):1061-7. PubMed ID: 21990280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a marker for two lineages within the GC1 clone of Acinetobacter baumannii.
    Hamidian M; Wynn M; Holt KE; Pickard D; Dougan G; Hall RM
    J Antimicrob Chemother; 2014 Feb; 69(2):557-8. PubMed ID: 24080502
    [No Abstract]   [Full Text] [Related]  

  • 19. Developing new therapeutic approaches for treating infections caused by multi-drug resistant Acinetobacter baumannii: Acinetobacter baumannii therapeutics.
    Gallagher P; Baker S
    J Infect; 2020 Dec; 81(6):857-861. PubMed ID: 33115656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroquinolone resistance conferred by gyrA, parC mutations, and AbaQ efflux pump among Acinetobacter baumannii clinical isolates causing ventilator-associated pneumonia.
    Attia NM; Elbaradei A
    Acta Microbiol Immunol Hung; 2019 Dec; 67(4):234-238. PubMed ID: 31833383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.